168 related articles for article (PubMed ID: 23525969)
1. The role of cysteines and histidins of the norepinephrine transporter.
Wenge B; Bönisch H
Neurochem Res; 2013 Jul; 38(7):1303-14. PubMed ID: 23525969
[TBL] [Abstract][Full Text] [Related]
2. Novel structure--function information on biogenic amine transporters revealed by site-directed mutagenesis and alkylation.
Reith ME
Neurochem Res; 2013 Jul; 38(7):1301-2. PubMed ID: 23532308
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [³H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive.
Zhen J; Ali S; Dutta AK; Reith ME
J Neurosci Methods; 2012 Jan; 203(1):19-27. PubMed ID: 21933682
[TBL] [Abstract][Full Text] [Related]
4. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
Strauss MJ; Porter KD; Quizon PM; Davis SE; Lin S; Yuan Y; Martinez-Muniz GA; Sun WL; Zhan CG; Zhu J
PLoS One; 2022; 17(9):e0275182. PubMed ID: 36170295
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.
Sucic S; Bryan-Lluka LJ
Eur J Pharmacol; 2007 Feb; 556(1-3):27-35. PubMed ID: 17141753
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
Foley KF; Cozzi NV
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
[TBL] [Abstract][Full Text] [Related]
7. N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.
Wenge B; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):255-65. PubMed ID: 18357440
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
Guptaroy B; Fraser R; Desai A; Zhang M; Gnegy ME
Mol Pharmacol; 2011 Mar; 79(3):520-32. PubMed ID: 21149640
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.
Paczkowski FA; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2001 Dec; 97(1):32-42. PubMed ID: 11744160
[TBL] [Abstract][Full Text] [Related]
10. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.
Paczkowski FA; Bönisch H; Bryan-Lluka LJ
Pharmacogenetics; 2002 Mar; 12(2):165-73. PubMed ID: 11875370
[TBL] [Abstract][Full Text] [Related]
12. Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport.
Danek Burgess KS; Justice JB
J Neurochem; 1999 Aug; 73(2):656-64. PubMed ID: 10428062
[TBL] [Abstract][Full Text] [Related]
13. Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.
Sucic S; Bryan-Lluka LJ
J Neurochem; 2005 Sep; 94(6):1620-30. PubMed ID: 16092934
[TBL] [Abstract][Full Text] [Related]
14. The role of the conserved GXXXRXG motif in the expression and function of the human norepinephrine transporter.
Sucic S; Bryan-Lluka LJ
Brain Res Mol Brain Res; 2002 Dec; 108(1-2):40-50. PubMed ID: 12480177
[TBL] [Abstract][Full Text] [Related]
15. A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
Wang CI; Shaikh NH; Ramu S; Lewis RJ
Mol Pharmacol; 2012 Nov; 82(5):898-909. PubMed ID: 22874414
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the splicing variants of human norepinephrine transporter.
Kitayama S; Morita K; Dohi T
Neurosci Lett; 2001 Oct; 312(2):108-12. PubMed ID: 11595346
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization.
Jayanthi LD; Annamalai B; Samuvel DJ; Gether U; Ramamoorthy S
J Biol Chem; 2006 Aug; 281(33):23326-40. PubMed ID: 16740633
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine.
Zhu MY; Blakely RD; Apparsundaram S; Ordway GA
J Neurochem; 1998 Apr; 70(4):1547-55. PubMed ID: 9523572
[TBL] [Abstract][Full Text] [Related]
19. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.
Melikian HE; McDonald JK; Gu H; Rudnick G; Moore KR; Blakely RD
J Biol Chem; 1994 Apr; 269(16):12290-7. PubMed ID: 8163533
[TBL] [Abstract][Full Text] [Related]
20. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
